赛场见证：专业运动员信赖的能量源泉 长森源红参饮料精准切中这一时代脉搏： 在绿茵场上，延边龙鼎足球队以坚韧不拔的意志与卓越体能驰骋赛场，其背后，是科学训练与精准营养 补给的强力支撑。作为延边龙鼎足球俱乐部官方指定营养补剂，长森源红参饮料以其卓越品质与功效， 成为球员们在激烈对抗中保持巅峰状态的重要"能量引擎"。这不仅是对产品实力的高度认可，更是长森 源品牌在健康饮品领域深耕细作、引领行业发展的有力证明。 匠心传承：源自长白山的自然精粹 长森源品牌的核心竞争力，深植于其对原料近乎严苛的把控与对传统滋补智慧的现代演绎。其红参饮料 的核心原料，甄选自长白山腹地，依托先进的生物萃取与低温浓缩技术，长森源最大化保留红参中的核 心活性物质，实现传统滋补精华的高效转化与吸收，赋予产品强大的健康赋能基础。 长森源红参饮料能成为延边龙鼎足球俱乐部的官方选择，绝非偶然。现代足球对运动员的体能储备、快 速恢复能力、抗疲劳水平及免疫系统稳定性提出极致要求，长森源红参饮料蕴含的丰富人参皂苷、多 糖、氨基酸及微量元素。 长森源红参饮料作为日常训练及赛前赛后指定补给，在帮助球员维持最佳竞技状态方面扮演了不可或缺 的角色，这份来自职业体育领 ...

Core Viewpoint - The severe flooding in Rongjiang County, Guizhou Province, has significantly impacted local residents' lives and posed challenges for flood relief and post-disaster public health protection. In response, Yiling Health Technology has donated health supplies to support relief efforts [1][3]. Group 1: Company Response - Yiling Health Technology donated 38,400 cans of Lianhua Qingfei plant beverage and 30,000 Lianhua Baozhu masks to the flood-affected area to aid in flood relief and health protection efforts [1][3]. - The donated Lianhua Qingfei plant beverage provides refreshing hydration for rescue workers and affected residents, while the masks help reduce the risk of disease transmission in the disaster area [3]. - A representative from Yiling Health emphasized the company's commitment to social responsibility and the importance of supporting affected communities during crises [3]. Group 2: Corporate Philanthropy - Yiling Health has a long-standing commitment to public welfare, having donated over 20 million yuan worth of health supplies to the Chinese Red Cross during the COVID-19 pandemic, supporting both domestic and international efforts [5]. - In 2021, Yiling Health launched the "Lianhua Respiratory Health Public Welfare Action" project, donating 50 million yuan in funds and materials for pandemic prevention and flood relief [5]. - The recent support for the Rongjiang disaster area is seen as a continuation of the company's philanthropic practices [5]. Group 3: Ongoing Commitment - Yiling Health will continue to monitor the disaster situation and fully support flood relief efforts, expressing confidence in the community's ability to rebuild [6].

Core Viewpoint - The company is facing challenges in its financial performance for 2024, with a significant decline in revenue and net profit, primarily due to strategic business adjustments and ongoing project developments [2]. Group 1: Financial Performance - In 2024, the company's operating revenue decreased by 13.89% year-on-year, resulting in a net profit loss [2]. - The decline in revenue and profit is attributed to the active contraction of the construction steel structure business, the ongoing trial production of the Shandong Lingkai project, and increased financial costs due to higher bank financing [2]. Group 2: Market Position and Competitive Advantage - The company has a strong market competitiveness and brand recognition in the pharmaceutical and health beverage sectors, with several products included in the medical insurance catalog [3]. - The company's health business segment, Huashen Blue Light, possesses rare mineral water resources, with its Biri 59 product having a silicate content of 59.99 mg/L, significantly exceeding national standards [3]. Group 3: Research and Development Focus - The company plans to focus on the in-depth exploration and secondary development of major traditional Chinese medicine products, particularly the Sanqi Tongshu capsules and Biyuan Shu, to enhance product application range and efficacy [4]. Group 4: Response to Industry Policy Changes - The company is closely monitoring changes in medical insurance payment reforms and drug procurement policies, aiming to enhance its risk resistance through market expansion and product quality management [5]. Group 5: New Market Expansion - The company is considering international market expansion based on its core traditional Chinese medicine products, which are recognized in the German Pharmacopoeia, while also planning to develop related health products and services [6]. Group 6: Asset Restructuring and Strategic Investment - The company will prudently evaluate asset restructuring and strategic investment opportunities based on its development strategy and market conditions [7].

在当前经济形势下，拉动内需、促进消费已成为确保中国经济持续向好的关键战略举措。与此同时，推 动中国品牌走出国门，让世界共享中国经济发展成果，以及中国式现代化带来的新动能，也具有愈发重 要的意义。2025年5月，中国国礼集团正式宣布与美国上市公司 FutureNet.Inc.（股票代码 FUUN）完成 全面合并，并顺利实现控股权交接。这一重大举措，标志着中国国礼集团迈入了全新的跨越式发展阶 段。 中国国礼集团业务涵盖生物美容、健康饮品、保健医疗、电子商务等多个领域。"国礼"作为国家形象的 展示窗口，承担着传递和平与友谊的重要使命。自成立以来，中国国礼集团始终秉持"国之重器，礼之 传承"的品牌精神，凭借创新理念、专业能力和高度责任感，致力于打造国家级礼品行业标准，积极履 行中国企业的社会责任。此次进军美国资本市场并成功上市，为中国国礼集团带来了新的发展机遇。通 过优化传播渠道，集团将能够全方位、多维度地向世界传播国礼价值，讲述国礼故事。未来，集团计划 构建一个包含优质企业、产品、品牌、渠道和买家的生态闭环系统，打造一个产、营、销相互支撑的产 品聚合平台。这不仅有助于提升战略性新兴产业的发展能力，还将推动形成万亿级 ...

中新网湖北新闻4月30日电 (胡传林 蔡祖峰 阮冰)湖北咸宁市政府新闻办29日举行"当好支点建设生力 军，加快打造武汉都市圈绿色发展重要增长极"系列主题新闻发布会，聚焦咸宁高新区科技创新与产业 创新融合发展情况。 连续举办创新赛事，推动80余家企业与30余所高校合作，促成超10亿元科技成果转化。引进元气森林华 中健康饮品研发中心，支持三环集团建设汽车零部件实验室冲刺国家级平台。咸宁(武汉)离岸科创园引 进25个科技项目，填补国内空白、打破技术垄断。成功创建多个国家级/省级创新型产业集群，提升产 业集聚效应。 聚焦"引智"：强化人才支撑体系 近年来，咸宁高新区以科技创新为核心引擎，通过"四个聚焦"推动创新链与产业链深度融合，为湖 北"建成支点"和武汉都市圈绿色发展提供强劲动能。 实施"人才强区"战略，三年投入1.5亿元引进各类人才9000余人(含国家院士专家)。通过"院士专家企业 行"等活动，组织专家解决技术难题70余项。推动世丰新材料与武汉理工大学、南玻光电与硅酸盐建筑 材料国家重点实验室合作，实现关键技术突破。 咸宁高新区致力于构建"科技型中小企业—高新技术企业—科创新物种企业"梯次培育体系，目前已培育 科 ...

长按扫码即可免费加入 风险提示：本文所提到的观点仅代表个人的意见，所涉及标的不作推荐，据此买卖，风险自负。 作者：高礼成蹊 来源：雪球 1. 啤酒 ： 高端化逻辑持续兑现 ， 青岛啤酒 （ ASP提升至4200元/千升 ） 、 燕京啤酒 （ U8大单 品收入占比超25% ） 受益于产品升级和成本下行 。 2. 软饮料 ： 一 、 白酒 ： 估值修复与龙头确定性 白酒板块当前PE-TTM仅19.31倍 ， 处于近10年6.18%分位 ， 安全边际突出 。 核心机会聚焦 ： 1. 高端白酒 ： 贵州茅台 、 $五粮液(SZ000858)$ 凭借 " 保价控量 " 策略和降维打击能力 ， 持续 巩固市场份额 ， 2024年净利润增速分别达13.3%和12.7% 。 2. 区域龙头 ： 山西汾酒 、 $今世缘(SH603369)$ 受益于渠道下沉和宴席场景复苏 ， 2025年春节 销售增速超30% 。 3. 次高端弹性标的 ： 古井贡酒 、 迎驾贡酒通过产品结构升级 （ 年份原浆占比提升至60%+ ） 驱动毛利率突破75% 。 催化因素 ： 两会消费提振政策预期 、 核心城市地产回暖带动商务消费复苏 。 二 、 大众 ...